177 related articles for article (PubMed ID: 34651027)
1. Complement Inhibition Targeted to Injury Specific Neoepitopes Attenuates Atherogenesis in Mice.
Dai S; Liu F; Ren M; Qin Z; Rout N; Yang XF; Wang H; Tomlinson S; Qin X
Front Cardiovasc Med; 2021; 8():731315. PubMed ID: 34651027
[No Abstract] [Full Text] [Related]
2. Natural IgM antibodies that bind neoepitopes exposed as a result of spinal cord injury , drive secondary injury by activating complement.
Narang A; Qiao F; Atkinson C; Zhu H; Yang X; Kulik L; Holers VM; Tomlinson S
J Neuroinflammation; 2017 Jun; 14(1):120. PubMed ID: 28629465
[TBL] [Abstract][Full Text] [Related]
3. A novel injury site-natural antibody targeted complement inhibitor protects against lung transplant injury.
Li C; Patel K; Tu Z; Yang X; Kulik L; Alawieh A; Allen P; Cheng Q; Wallace C; Kilkenny J; Kwon J; Gibney B; Cantu E; Sharma A; Pipkin M; Machuca T; Emtiazjoo A; Goddard M; Holers VM; Nadig S; Christie J; Tomlinson S; Atkinson C
Am J Transplant; 2021 Jun; 21(6):2067-2078. PubMed ID: 33210808
[TBL] [Abstract][Full Text] [Related]
4. C2 IgM Natural Antibody Enhances Inflammation and Its Use in the Recombinant Single Chain Antibody-Fused Complement Inhibitor C2-Crry to Target Therapeutics to Joints Attenuates Arthritis in Mice.
Banda NK; Tomlinson S; Scheinman RI; Ho N; Ramirez JR; Mehta G; Wang G; Vu VP; Simberg D; Kulik L; Holers VM
Front Immunol; 2020; 11():575154. PubMed ID: 33178202
[TBL] [Abstract][Full Text] [Related]
5. Targeted mouse complement inhibitor CR2-Crry protects against the development of atherosclerosis in mice.
Liu F; Wu L; Wu G; Wang C; Zhang L; Tomlinson S; Qin X
Atherosclerosis; 2014 May; 234(1):237-43. PubMed ID: 24685815
[TBL] [Abstract][Full Text] [Related]
6. Targeting pathogenic postischemic self-recognition by natural IgM to protect against posttransplantation cardiac reperfusion injury.
Atkinson C; Qiao F; Yang X; Zhu P; Reaves N; Kulik L; Goddard M; Holers VM; Tomlinson S
Circulation; 2015 Mar; 131(13):1171-80. PubMed ID: 25825397
[TBL] [Abstract][Full Text] [Related]
7. Role of IgM and angiotensin II Type I receptor autoantibodies in local complement activation in placental ischemia-induced hypertension in the rat.
Regal JF; Strehlke ME; Peterson JM; Wing CR; Parker JE; Nieto NF; Bemis LT; Gilbert JS; Fleming SD
Mol Immunol; 2016 Oct; 78():38-47. PubMed ID: 27588825
[TBL] [Abstract][Full Text] [Related]
8. Natural immunoglobulin M initiates an inflammatory response important for both hepatic ischemia reperfusion injury and regeneration in mice.
Marshall K; Jin J; Atkinson C; Alawieh A; Qiao F; Lei B; Chavin KD; He S; Tomlinson S
Hepatology; 2018 Feb; 67(2):721-735. PubMed ID: 28880403
[TBL] [Abstract][Full Text] [Related]
9. Increasing the efficacy and safety of a human complement inhibitor for treating post-transplant cardiac ischemia reperfusion injury by targeting to a graft-specific neoepitope.
Zheng C; Sleiman MM; Yang X; He S; Atkinson C; Tomlinson S
J Heart Lung Transplant; 2021 Oct; 40(10):1112-1121. PubMed ID: 34334299
[TBL] [Abstract][Full Text] [Related]
10. A role for P-selectin and complement in the pathological sequelae of germinal matrix hemorrhage.
Hatchell D; Alshareef M; Vasas T; Guglietta S; Borucki D; Guo C; Mallah K; Eskandari R; Tomlinson S
J Neuroinflammation; 2023 Jun; 20(1):143. PubMed ID: 37322469
[TBL] [Abstract][Full Text] [Related]
11. A single-chain antibody construct with specificity of a natural IgM antibody reduces hepatic ischemia reperfusion injury in mice.
Yang Z; Li C; Wang Y; Dong W; Yang M; Jin J
J Cell Mol Med; 2024 Apr; 28(8):e18291. PubMed ID: 38597412
[TBL] [Abstract][Full Text] [Related]
12. A Role for P-selectin and Complement in the Pathological Sequelae of Germinal Matrix Hemorrhage.
Hatchell D; Alshareef M; Vasas T; Guglietta S; Borucki D; Guo C; Mallah K; Eskandari R; Tomlinson S
Res Sq; 2023 Feb; ():. PubMed ID: 36909595
[No Abstract] [Full Text] [Related]
13. Tissue-specific deletion of Crry from mouse proximal tubular epithelial cells increases susceptibility to renal ischemia-reperfusion injury.
Miao J; Lesher AM; Miwa T; Sato S; Gullipalli D; Song WC
Kidney Int; 2014 Oct; 86(4):726-37. PubMed ID: 24850152
[TBL] [Abstract][Full Text] [Related]
14. Targeted Complement Inhibition Protects Vascularized Composite Allografts From Acute Graft Injury and Prolongs Graft Survival When Combined With Subtherapeutic Cyclosporine A Therapy.
Zhu P; Bailey SR; Lei B; Paulos CM; Atkinson C; Tomlinson S
Transplantation; 2017 Apr; 101(4):e75-e85. PubMed ID: 28045880
[TBL] [Abstract][Full Text] [Related]
15. A complement C3 inhibitor specifically targeted to sites of complement activation effectively ameliorates collagen-induced arthritis in DBA/1J mice.
Song H; Qiao F; Atkinson C; Holers VM; Tomlinson S
J Immunol; 2007 Dec; 179(11):7860-7. PubMed ID: 18025232
[TBL] [Abstract][Full Text] [Related]
16. Complement Inhibition Alleviates Cholestatic Liver Injury Through Mediating Macrophage Infiltration and Function in Mice.
Guo Z; Chen J; Zeng Y; Wang Z; Yao M; Tomlinson S; Chen B; Yuan G; He S
Front Immunol; 2021; 12():785287. PubMed ID: 35069557
[TBL] [Abstract][Full Text] [Related]
17. Pathogenic natural antibodies propagate cerebral injury following ischemic stroke in mice.
Elvington A; Atkinson C; Kulik L; Zhu H; Yu J; Kindy MS; Holers VM; Tomlinson S
J Immunol; 2012 Feb; 188(3):1460-8. PubMed ID: 22198950
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of complement inhibitor Crry does not prevent cryoglobulin-associated membranoproliferative glomerulonephritis.
Mühlfeld AS; Segerer S; Hudkins K; Farr AG; Bao L; Kraus D; Holers VM; Quigg RJ; Alpers CE
Kidney Int; 2004 Apr; 65(4):1214-23. PubMed ID: 15086460
[TBL] [Abstract][Full Text] [Related]
19. Mesangial cell complement receptor 1-related protein y limits complement-dependent neutrophil accumulation in immune complex glomerulonephritis.
Bao L; Wang Y; Chen P; Sarav M; Haas M; Minto AW; Petkova M; Quigg RJ
Immunology; 2009 Sep; 128(1 Suppl):e895-904. PubMed ID: 19740350
[TBL] [Abstract][Full Text] [Related]
20. Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection.
Atkinson C; Song H; Lu B; Qiao F; Burns TA; Holers VM; Tsokos GC; Tomlinson S
J Clin Invest; 2005 Sep; 115(9):2444-53. PubMed ID: 16127466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
